Measurement of 131I activity in thyroid of nuclear medical staff and internal dose assessment in a Polish nuclear medical hospital

被引:0
|
作者
K. Brudecki
A. Kowalska
P. Zagrodzki
A. Szczodry
T. Mroz
P. Janowski
J. W. Mietelski
机构
[1] Polish Academy of Sciences,Institute of Nuclear Physics
[2] Holy Cross Cancer Center,Department of Endocrinology and Nuclear Medicine
[3] Pedagogical University in Cracow,Department of Food Chemistry and Nutrition, Medical College
[4] AGH University of Science and Technology,undefined
[5] Jagiellonian University,undefined
来源
关键词
I; Thyroid; Nuclear medicine; Medical personnel; Internal doses;
D O I
暂无
中图分类号
学科分类号
摘要
This paper presents results of 131I thyroid activity measurements in 30 members of the nuclear medicine personnel of the Department of Endocrinology and Nuclear Medicine Holy Cross Cancer Centre in Kielce, Poland. A whole-body spectrometer equipped with two semiconductor gamma radiation detectors served as the basic research instrument. In ten out of 30 examined staff members, the determined 131I activity was found to be above the detection limit (DL = 5 Bq of 131I in the thyroid). The measured activities ranged from (5 ± 2) Bq to (217 ± 56) Bq. The highest activities in thyroids were detected for technical and cleaning personnel, whereas the lowest values were recorded for medical doctors. Having measured the activities, an attempt has been made to estimate the corresponding annual effective doses, which were found to range from 0.02 to 0.8 mSv. The highest annual equivalent doses have been found for thyroid, ranging from 0.4 to 15.4 mSv, detected for a cleaner and a technician, respectively. The maximum estimated effective dose corresponds to 32% of the annual background dose in Poland, and to circa 4% of the annual limit for the effective dose due to occupational exposure of 20 mSv per year, which is in compliance with the value recommended by the International Commission on Radiological Protection.
引用
收藏
页码:19 / 26
页数:7
相关论文
共 50 条
  • [21] 131I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine
    K. Brudecki
    A. Kluczewska-Gałka
    P. Zagrodzki
    B. Jarząb
    K. Gorzkiewicz
    T. Mróz
    Radiation and Environmental Biophysics, 2020, 59 : 559 - 564
  • [22] Intercomparison of 131I measurements using dose calibrator in nuclear medicine services of Thailand
    Soodprasert, T
    Nunthawarasilp, T
    Proceedings of 44th Kasetsart University Annual Conference: AGRICULTURAL SCIENCE: CARRYING FORWARD THE ROYAL BIO-ENERGY INITIATIVE, 2006, : 260 - 266
  • [23] National comparison of 131I measurement among nuclear medicine clinics of eight countries
    Olsovcova, Veronika
    Iwahara, Akira
    Oropesa, Pilar
    Joseph, Leena
    Ravindra, Anuradha
    Ghafoori, Mostafa
    Son, Hye-Kyung
    Sahagia, Maria
    Tastan, Selma
    Zimmerman, Brian
    APPLIED RADIATION AND ISOTOPES, 2010, 68 (7-8) : 1371 - 1377
  • [24] Dose reduction of 131i ablative therapy for treatment differentiated thyroid cancer in a hospital setting
    Lima, A.
    Garcia-Burillo, A.
    Soriano, B.
    Quera, M.
    Moga, M.
    Modamio, P.
    Castell, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 986 - 986
  • [25] Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests
    Archer, VE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (16) : 1423 - 1424
  • [26] Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests
    Gilbert, ES
    Tarone, R
    Bouville, A
    Ron, E
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (21): : 1654 - 1660
  • [27] Thyroid Cancer Patients Treated with 131I: Radiation Dose to Relatives After Discharge from the Hospital
    Herve, Remy
    Jeremy, Coulot
    Isabelle, Borget
    Marcel, Ricard
    Nadine, Guilabert
    Frederic, Lavielle
    Eve, Camps
    Eric, Baudin
    Jean, Lumbroso
    Sophie, Leboulleux
    Martin, Schlumberger
    THYROID, 2012, 22 (01) : 59 - 63
  • [28] Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests -: Response
    Gilbert, ES
    Tarone, R
    Bouville, A
    Ron, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (16) : 1424 - 1425
  • [29] Thyroid Cancer Rates and 131I Doses from Nevada Atmospheric Nuclear Bomb Tests: An Update
    Gilbert, Ethel S.
    Huang, Lan
    Bouville, Andre
    Berg, Christine D.
    Ron, Elaine
    RADIATION RESEARCH, 2010, 173 (05) : 659 - 664
  • [30] Thyroid ultrasound abnormalities in persons exposed during childhood to 131I from the Hanford Nuclear Site
    Kopecky, KJ
    Onstad, L
    Hamilton, TE
    Davis, S
    THYROID, 2005, 15 (06) : 604 - 613